Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAberdeen Asia Regulatory News (AAS)

Share Price Information for Aberdeen Asia (AAS)

Share Price is delayed by 15 minutes
Get Live Data
419.00    1.00 (0.24%)
Bid:
421.00
Ask:
422.00
Spread: 1.00 (0.238%)
Market Cap: £580.02m
AAS Live PriceLast checked at - London Stock Exchange

Intraday Aberdeen Asia Share Chart

Director/PDMR Shareholding

5 Aug 2024 14:27

RNS Number : 2322Z
abrdn Asia Focus plc
05 August 2024
 

ABRDN ASIA FOCUS PLC

Legal Entity Identifier (LEI): 5493000FBZP1J92OQY70

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

LUCY MACDONALD

2

Reason for the notification

a)

Position/status

NON EXECUTIVE DIRECTOR

b)

Initial notification/ Amendment

INITIAL NOTIFICATION

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

ABRDN ASIA FOCUS PLC

b)

LEI

5493000FBZP1J92OQY70

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

ORDINARY 5P SHARES

GB00BMF19B58

b)

Nature of the transaction

SHARE PURCHASE

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£2.595825

12,000

d)

Aggregated information

 - Aggregated volume

- Price

 

N/A - single transaction

N/A - single transaction

e)

Date of the transaction

05/08/24

f)

Place of the transaction

LONDON STOCK EXCHANGE, MAIN MARKET (XLON)

 

Following this transaction the total beneficial Interest for LUCY MACDONALD is 12,000 Ordinary 5p Shares

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBXGDIUDGDGSU
Date   Source Headline
24th Apr 20265:04 pmRNSTransaction in Own Shares
24th Apr 202611:25 amRNSNet Asset Value(s)
23rd Apr 20265:10 pmRNSTransaction in Own Shares
23rd Apr 202610:50 amRNSNet Asset Value(s)
22nd Apr 20265:07 pmRNSTransaction in Own Shares
22nd Apr 202611:31 amRNSNet Asset Value(s)
21st Apr 20265:16 pmRNSTransaction in Own Shares
21st Apr 202611:36 amRNSNet Asset Value(s)
20th Apr 20265:09 pmRNSTransaction in Own Shares
20th Apr 20263:22 pmRNSOnline Investor Presentation – 5 May 2026
20th Apr 20261:14 pmRNSGearing Disclosures
20th Apr 202612:18 pmRNSNet Asset Value(s)
17th Apr 202611:36 amRNSNet Asset Value(s)
16th Apr 202610:41 amRNSNet Asset Value(s)
15th Apr 202611:10 amRNSNet Asset Value(s)
14th Apr 202611:05 amRNSNet Asset Value(s)
13th Apr 20263:07 pmRNSGearing disclosure
13th Apr 202612:26 pmRNSNet Asset Value(s)
13th Apr 20269:04 amRNSPortfolio disclosure
13th Apr 20267:00 amRNS-RKepler Trust Intelligence: New Research
10th Apr 20265:06 pmRNSTransaction in Own Shares
10th Apr 202611:58 amRNSNet Asset Value(s)
10th Apr 202611:35 amRNSDoc re. Half-Yearly Report
10th Apr 20267:00 amRNSRetirement of Director
9th Apr 202611:23 amRNSNet Asset Value(s)
8th Apr 20262:00 pmRNSMonth End Net Asset Value(s)
8th Apr 202611:45 amRNSNet Asset Value(s)
7th Apr 20261:14 pmRNSGearing Disclosure
7th Apr 202612:19 pmRNSNet Asset Value(s)
1st Apr 20269:29 amRNSTotal Voting Rights
31st Mar 202611:58 amRNSNet Asset Value(s)
30th Mar 20265:07 pmRNSTransaction in Own Shares
30th Mar 20263:13 pmRNSGearing disclosure
30th Mar 202612:16 pmRNSNet Asset Value(s)
30th Mar 20267:00 amRNSHalf-year Financial Report
27th Mar 202611:54 amRNSNet Asset Value(s)
26th Mar 202611:51 amRNSNet Asset Value(s)
25th Mar 202611:42 amRNSNet Asset Value(s)
24th Mar 20265:07 pmRNSTransaction in Own Shares
24th Mar 202611:18 amRNSNet Asset Value(s)
24th Mar 202610:42 amRNSGearing Disclosures
23rd Mar 202612:17 pmRNSNet Asset Value(s)
20th Mar 20265:08 pmRNSTransaction in Own Shares
20th Mar 202611:50 amRNSNet Asset Value(s)
19th Mar 20265:25 pmRNSTransaction in Own Shares
19th Mar 202611:58 amRNSNet Asset Value(s)
18th Mar 202612:22 pmRNSNet Asset Value(s)
17th Mar 202610:40 amRNSNet Asset Value(s)
16th Mar 20265:09 pmRNSTransaction in Own Shares
16th Mar 20262:10 pmRNSGearing disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.